When two formulations are compared, a randomized, two-period, two-sequence single dose crossover design is standard design. The treatment periods should be separated by a wash out period sufficient to ensure that drug concentrations are below the lower limit of bioanalytical quantification in all subjects at the beginning of the second period. Normally at least 5 elimination longest half-lives are necessary to achieve this.
ekleelpharma.com 